Child Categories
Food & Drug Law
-
Mason Marks, Rebecca W. Brendel, Carmel Shachar et al., Essentials of Informed Consent to Psychedelic Medicine, 81 JAMA Psychiatry 611 (2024).
-
Proposed Nutrition Competencies for Medical Students and Physician Trainees: A Consensus Statement
July 3, 2025
David M. Eisenberg, Alexis Cole, Edward J. Maile et al., Proposed Nutrition Competencies for Medical Students and Physician Trainees: A Consensus Statement, 7 JAMA Network…
-
The Time is Ripe: The Case for Nutrition in Graduate Medical Education in the United States
July 3, 2025
Bethany Agusala, Emily Broad Leib & Jaclyn Albin, The Time is Ripe: The Case for Nutrition in Graduate Medical Education in the United States, 11…
-
Annabel Kupke, Carmel Shachar & Christopher Robertson, Pulse Oximeters and Violation of Federal Antidiscrimination Law, 329 JAMA 365 (2023).
-
Drinking Water: A History
July 2, 2025
James Salzman, Drinking Water: A History (2d ed. 2017).
-
The Evolution and Scope of Medicaid Section 1115 Demonstrations to Address Nutrition: A U.S. Survey
July 2, 2025
Erika Hanson, Daniel Albert-Rozenberg, Kathryn M. Garfield et al., The Evolution and Scope of Medicaid Section 1115 Demonstrations to Address Nutrition: A U.S. Survey, 2…
-
Drug Product Liability at the Crossroads
July 2, 2025
Peter Grossi & Keri Arnold, Drug Product Liability at the Crossroads, in The Oxford Handbook of U.S. Health Law (I. Glenn Cohen, Allison K. Hoffman…
-
FDA preemption of conflicting state drug regulation and the looming battle over abortion medications
July 2, 2025
Peter Grossi & Daphne O’Connor, FDA preemption of conflicting state drug regulation and the looming battle over abortion medications, 10 J. L. Biosciences (2023).
-
Regulatory, Safety, and Privacy Concerns of Home Monitoring Technologies During COVID-19
June 27, 2025
Sara Gerke, Carmel Shachar, Peter R. Chai & I. Glenn Cohen, Regulatory, Safety, and Privacy Concerns of Home Monitoring Technologies During COVID-19, 26 Nature Med.
-
How Should the FDA Evaluate Psychedelic Medicine?
June 25, 2025
Mason Marks & I. Glenn Cohen, How Should the FDA Evaluate Psychedelic Medicine?, 389 New England J. Med. 1733 (2023).
-
Mason Marks & I. Glenn Cohen, Psychedelic Therapy: A Roadmap for Wider Acceptance and Utilization, 27 Nat. Med. 1669 (2021).
-
Ten Years Post-GAO Assessment, FDA Remains Uninformed of Potentially Harmful GRAS Substances in Foods
June 25, 2025
Cameron Faustman, Daniel Aaron, Nicole Negowetti & Emily Broad Leib, Ten Years Post-GAO Assessment, FDA Remains Uninformed of Potentially Harmful GRAS Substances in Foods, 61…
-
Jennifer L. Pomeranz, Sean B. Cash, Emily Broad Leib et al., Advancing The FDA’s Human Foods Program Through Additional Authorities And User Fees, 44 Health…
-
The Need For a System View to Regulate Artificial Intelligence/Machine Learning-Based Software as Medical Device
June 20, 2025
Sara Gerke, Boris Babic, Theodoros Evgeniou & I. Glenn Cohen, The Need For a System View to Regulate Artificial Intelligence/Machine Learning-Based Software as Medical Device,…
-
John H. Rex, Holly Fernandez Lynch, I. Glenn Cohen, Jonathan J. Darrow & Kevin Outterson, Designing Development Programs for Non-Traditional Antibacterial Agents, 10 Nature Comm.
-
Ingesting Risk – The FDA and New Food Ingredients
June 19, 2025
Pieter A. Cohen & Emily M. Broad Leib, Ingesting Risk – The FDA and New Food Ingredients, 391 New England J. Med. 875 (2024).
-
Stephen Devries & Emily Broad Leib, Nutrition education in medical training: it’s always been a matter of trust, 120 Am. J. Clinical Nutrition 465 (2024).
-
Katharine Van Tassel, Carmel Shachar & Sharona Hoffman, Covid-19 Vaccine Injuries — Preventing Inequities in Compensation, New England J. Med. (2021).